UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 447

Sortiert nach

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor Myrcludex B

Journal of hepatology, 2016-09, Vol.65 (3), p.483-489

2016

Volltextzugriff (PDF)

Frailty and healthcare costs—longitudinal results of a prospective cohort study

Age and ageing, 2018-03, Vol.47 (2), p.233-241

2018

Volltextzugriff (PDF)

Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms

European journal of clinical pharmacology, 2013-04, Vol.69 (4), p.937-948

2013

Volltextzugriff (PDF)

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

BMC cancer, 2018-12, Vol.18 (1), p.1210-1210, Article 1210

2018

Volltextzugriff (PDF)

A framework to build similarity-based cohorts for personalized treatment advice - a standardized, but flexible workflow with the R package SimBaCo

PloS one, 2020-05, Vol.15 (5), p.e0233686-e0233686

2020

Volltextzugriff (PDF)

CYP3A activity: towards dose adaptation to the individual

Expert opinion on drug metabolism & toxicology, 2016-05, Vol.12 (5), p.479-497

2016

Volltextzugriff (PDF)

Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole

Clinical pharmacokinetics, 2016-12, Vol.55 (12), p.1535-1545

2016

Volltextzugriff (PDF)

Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions

PloS one, 2021-04, Vol.16 (4), p.e0250298-e0250298

2021

Volltextzugriff (PDF)

Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trial

PloS one, 2019-02, Vol.14 (2), p.e0212007-e0212007

2019

Volltextzugriff (PDF)

RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans

Biomedicine & pharmacotherapy, 2024-04, Vol.173, p.116450-116450, Article 116450

2024

Volltextzugriff (PDF)

Identification, Biosynthesis, and Decapping of NAD-Capped RNAs in B. subtilis

Cell reports (Cambridge), 2018-08, Vol.24 (7), p.1890-1901.e8

2018

Volltextzugriff (PDF)

Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC–MS/MS-Based Assay

Analytical chemistry (Washington), 2018-08, Vol.90 (15), p.9395-9402

2018

Volltextzugriff (PDF)

Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections

International journal of molecular sciences, 2023-05, Vol.24 (10), p.8469

2023

Volltextzugriff (PDF)

Correction: Bay et al. Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. Int. J. Mol. Sci. 2022, 23 , 3637

International journal of molecular sciences, 2023-03, Vol.24 (5), p.5029

2023

Volltextzugriff (PDF)

7-Aminoactinomycin D for apoptosis staining in flow cytometry

Analytical biochemistry, 2012-10, Vol.429 (1), p.79-81

2012

Volltextzugriff (PDF)

The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study

PloS one, 2018-07, Vol.13 (7), p.e0198004-e0198004

2018

Volltextzugriff (PDF)

Treatment with Edoxaban Attenuates Acute Stroke Severity in Mice by Reducing Blood–Brain Barrier Damage and Inflammation

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9893

2021

Volltextzugriff (PDF)

An Underestimated Factor: The Extent of Cross-Reactions Modifying APIs in Surface-Modified Liposomal Preparations Caused by Comprised Activated Lipids

Molecules (Basel, Switzerland), 2020-09, Vol.25 (19), p.4436

2020

Volltextzugriff (PDF)

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach

Cardiovascular drugs and therapy, 2024-08, Vol.38 (4), p.747-756

2024

Volltextzugriff (PDF)

Plasma Drug Concentrations in Children Receiving Pulmonary Arterial Hypertension Combination Treatment

Respiration, 2019-01, Vol.97 (1), p.92-92

2019

Volltextzugriff (PDF)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters

Pharmaceutics, 2020-09, Vol.12 (10), p.919

2020

Volltextzugriff (PDF)

Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)

Oncoimmunology, 2017-01, Vol.6 (9), p.e1326440-e1326440

2017

Volltextzugriff (PDF)

Drug–Drug Interactions with Direct Oral Anticoagulants

Clinical pharmacokinetics, 2020-08, Vol.59 (8), p.967-980

2020

Volltextzugriff (PDF)

Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future Perspectives

Molecules (Basel, Switzerland), 2021-02, Vol.26 (5), p.1281

2021

Volltextzugriff (PDF)

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(429)
Mit Volltextzugriff
(394)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(417)
Japanisch
(45)
Deutsch
(28)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor Myrcludex B

Frailty and healthcare costs—longitudinal results of a prospective cohort study

Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

A framework to build similarity-based cohorts for personalized treatment advice - a standardized, but flexible workflow with the R package SimBaCo

CYP3A activity: towards dose adaptation to the individual

Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole

Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions

Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trial

RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans

Identification, Biosynthesis, and Decapping of NAD-Capped RNAs in B. subtilis

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model

Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC–MS/MS-Based Assay

Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections

Correction: Bay et al. Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. Int. J. Mol. Sci. 2022, 23 , 3637

7-Aminoactinomycin D for apoptosis staining in flow cytometry

The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study

Treatment with Edoxaban Attenuates Acute Stroke Severity in Mice by Reducing Blood–Brain Barrier Damage and Inflammation

An Underestimated Factor: The Extent of Cross-Reactions Modifying APIs in Surface-Modified Liposomal Preparations Caused by Comprised Activated Lipids

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach

Plasma Drug Concentrations in Children Receiving Pulmonary Arterial Hypertension Combination Treatment

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters

Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)

Drug–Drug Interactions with Direct Oral Anticoagulants

Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future Perspectives

Suchergebnisse filtern